Related Experiment Video
Updated: Jun 12, 2026

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Osteoporosis and inflammation
Paulo Gustavo Sampaio Lacativa1, Maria Lucia Fleiuss de Farias
1Departamento de Medicina Interna, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, RJ, Brasil. pglaca@yahoo.com <pglaca@yahoo.com>
Inflammatory diseases like rheumatoid arthritis are linked to bone loss and fracture risk, independent of other factors. New treatments targeting inflammation show promise for managing this secondary osteoporosis.
Area of Science:
- Rheumatology
- Immunology
- Endocrinology
Background:
- Several inflammatory diseases are linked to increased bone resorption and osteoporosis.
- The pathogenesis involves osteoclasts, macrophage colony-stimulating factor, and pro-inflammatory cytokines like TNF-alpha and IL-1.
- This association contributes to a high fracture risk, independent of common risk factors.
Purpose of the Study:
- To explore the association between inflammatory diseases and osteoporosis.
- To discuss the mechanisms linking inflammation to bone loss.
- To review current and emerging therapeutic strategies.
Main Methods:
- Literature review of inflammatory diseases associated with bone resorption.
- Analysis of the role of inflammatory mediators in osteoporosis.
- Evaluation of diagnostic indicators and therapeutic options.
Main Results:
- Rheumatoid arthritis, lupus, IBD, celiac disease, CF, and COPD are associated with bone resorption.
- Inflammation-induced osteoporosis is independent of factors like poor nutrition or glucocorticoid use.
- ESR and CRP are key inflammatory markers; densitometry timing requires disease-specific analysis.
Conclusions:
- Inflammatory diseases significantly contribute to osteoporosis and fracture risk.
- Understanding the inflammatory pathways is crucial for managing bone loss.
- Bisphosphonates are current standard, with biologics like denosumab and cytokine inhibitors offering future therapeutic avenues.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Inflammation
The Effect of Aging on Tissues